Published in Blood Weekly, November 6th, 2008
"In a prospective, multicenter, randomized, controlled clinical study, Rheopheresis-a method of therapeutic apheresis-was compared with a standard therapy consisting of either intravenous corticosteroids or hemodilution using pure-tone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-11-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.